FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Sci / Efficacy and Safety of Subcutaneous Allergen-Specific Immuno...
Veterinary sciences2023; 10(10); doi: 10.3390/vetsci10100613

Efficacy and Safety of Subcutaneous Allergen-Specific Immuno-Therapy in Horses with Allergic Cutaneous and Respiratory Diseases-A Systematic Review.

Abstract: Allergen-specific immunotherapy (AIT) is the only current intervention that has the ability to modify the immune response toward a tolerogenic state. This study aimed to assess the efficacy and safety of AIT in horses with allergic diseases in a systematic manner. Three databases were searched to identify articles reporting clinical outcomes and adverse events associated with AIT. The articles were evaluated for beneficial responses to AIT, defined as a ≥50% reduction in clinical signs, and clinical remission. Horses with respiratory diseases, urticaria, and pruritic dermatitis receiving insect monotherapy or multi-allergen AIT were included. All adverse events were graded, and analytical and confounding biases were assessed. The results showed that multi-allergen AIT had a beneficial response in 75% of horses with respiratory diseases, 88% with urticaria, and 56% with pruritic dermatitis. However, horses treated solely with insect AIT for pruritic dermatitis had a lower response rate (36%). Self-limiting local reactions were the most common adverse events, with systemic reactions grade II accounting for 11% of reported events. Analytical and confounding biases were identified as major limitations in the available studies. Further research is needed to address these biases and provide stronger evidence on the efficacy and safety of AIT in horses with allergic diseases.
Get Full Text
Publication Date: 2023-10-10 PubMed ID: 37888565PubMed Central: PMC10611411DOI: 10.3390/vetsci10100613Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses an evaluation of the efficacy and safety of allergen-specific immunotherapy (AIT) used to treat horses with allergic diseases such as respiratory diseases, urticaria, and pruritic dermatitis. The study, involving a systematic review design, found that the treatment had varying levels of success, with the highest observed in horses with respiratory diseases, and fewer side-effects reported were mostly of self-limiting local reactions.

Research Method

  • The research was conducted through a systematic review of articles selected from three databases. These articles reported on the clinical outcomes and any adverse events related to the use of AIT in the treatment of horses with allergic diseases.
  • The researchers included horses with respiratory diseases, urticaria, and pruritic dermatitis who had received insect monotherapy or multi-allergen AIT treatment in this study.
  • Beneficial responses to AIT were defined as having a reduction of 50% or more in the clinical signs of the disease and achieving clinical remission.

Results and Findings

  • The study found that 75% of horses with respiratory diseases, 88% with urticaria, and 56% with pruritic dermatitis benefited from multi-allergen AIT treatment.
  • However, when only insect AIT was used to treat pruritic dermatitis, the response rate was lower at 36%.
  • While AIT was generally safe, the most commonly reported side effects were self-limiting local reactions. Systemic reactions of grade II accounted for 11% of the reported events.

Limitations and Future Recommendations

  • The study identified analytical and confounding biases in the reviewed articles as a major limitation preventing a definitive conclusion on the efficacy and safety of AIT.
  • To address these biases, further research is necessary which can help provide stronger evidence to support the use of AIT in treating allergic diseases in horses.

Cite This Article

APA
Herrmann I, Sanchez AJ. (2023). Efficacy and Safety of Subcutaneous Allergen-Specific Immuno-Therapy in Horses with Allergic Cutaneous and Respiratory Diseases-A Systematic Review. Vet Sci, 10(10). https://doi.org/10.3390/vetsci10100613

Publication

Veterinary sciences
ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 10
Issue: 10

Researcher Affiliations

Herrmann, Ina
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
Sanchez, Adrianna Jordan
  • Department of Animal Sciences, College of Agriculture and Life Sciences, North Carolina State University, Raleigh, NC 27606, USA.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 53 references
  1. Marsella R, White S, Fadok V.A, Wilson D, Mueller R, Outerbridge C, Rosenkrantz W. Equine Allergic Skin Diseases: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Vet. Dermatol. 2023;34:175–208.
    doi: 10.1111/vde.13168pubmed: 37154488google scholar: lookup
  2. Couetil L, Cardwell J.M, Leguillette R, Mazan M, Richard E, Bienzle D, Bullone M, Gerber V, Ivester K, Lavoie J.-P. Equine Asthma: Current Understanding and Future Directions. Front. Vet. Sci. 2020;7:450.
    doi: 10.3389/fvets.2020.00450pmc: PMC7438831pubmed: 32903600google scholar: lookup
  3. Mainguy-Seers S, Lavoie J.-P. Glucocorticoid Treatment in Horses with Asthma: A Narrative Review. J. Vet. Intern. Med. 2021;35:2045–2057.
    doi: 10.1111/jvim.16189pmc: PMC8295667pubmed: 34085342google scholar: lookup
  4. Cuming R.S, Groover E.S, Wooldridge A.A, Caldwell F.J. Review of Glucocorticoid Therapy in Horses. Part 1: Pharmacology. Equine Vet. Educ. 2018;30:141–150.
    doi: 10.1111/eve.12555google scholar: lookup
  5. Olsén L, Bondesson U, Broström H, Olsson U, Mazogi B, Sundqvist M, Tjälve H, Ingvast-Larsson C. Pharmacokinetics and Effects of Cetirizine in Horses with Insect Bite Hypersensitivity. Vet. J. 2011;187:347–351.
    doi: 10.1016/j.tvjl.2009.12.030pubmed: 20097587google scholar: lookup
  6. Mueller R.S, Jensen-Jarolim E, Roth-Walter F, Marti E, Janda J, Seida A.A, Deboer D. Allergen Immunotherapy in People, Dogs, Cats and Horses—Differences, Similarities and Research Needs. Allergy Eur. J. Allergy Clin. Immunol. 2018;73:1989–1999.
    doi: 10.1111/all.13464pubmed: 29675865google scholar: lookup
  7. Alvarez-Cuesta E, Bousquet J, Canonica G.W, Durham S.R, Malling H.-J, Valovirta E. Standards for Practical Allergen-Specific Immunotherapy. Allergy 2006;61:1–3.
    doi: 10.1111/j.1398-9995.2006.01219_1.xpubmed: 16930249google scholar: lookup
  8. Page M.J, McKenzie J.E, Bossuyt P.M, Boutron I, Hoffmann T.C, Mulrow C.D, Shamseer L, Tetzlaff J.M, Akl E.A, Brennan S.E. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. Syst. Rev. 2021;10:89.
    doi: 10.1186/s13643-021-01626-4pmc: PMC8008539pubmed: 33781348google scholar: lookup
  9. Cox L, Larenas-Linnemann D, Lockey R.F, Passalacqua G. Speaking the Same Language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J. Allergy Clin. Immunol. 2010;125:569–574.e7.
    doi: 10.1016/j.jaci.2009.10.060pubmed: 20144472google scholar: lookup
  10. Passalacqua G, Baena-Cagnani C.E, Bousquet J, Canonica G.W, Casale T.B, Cox L, Durham S.R, Larenas-Linnemann D, Ledford D, Pawankar R. Grading Local Side Effects of Sublingual Immunotherapy for Respiratory Allergy: Speaking the Same Language. J. Allergy Clin. Immunol. 2013;132:93–98.
    doi: 10.1016/j.jaci.2013.03.039pubmed: 23683513google scholar: lookup
  11. Herrmann I, Loft K.E, Olivry T. Shortened Immunotherapy Dose-Escalation Saves Time, but Is It Safe? A Case-Control Study Comparing the Rates of Adverse Reactions between Conventional and Fast-Escalation Subcutaneous Immunotherapy Protocols during the Induction Phase. Vet. Dermatol. 2020;31:454-e120.
    doi: 10.1111/vde.12892pubmed: 32940395google scholar: lookup
  12. White S.D. Approach to the Pruritic Horse. J. Am. Vet. Med. Assoc. 2023;261:S66–S74.
    doi: 10.2460/javma.22.10.0444pubmed: 36638000google scholar: lookup
  13. Friberg C.A, Logas D. Treatment of Culicoides Hypersensitive Horses with High-Dose n-3 Fatty Acids: A Double-Blinded Crossover Study. Vet. Dermatol. 1999;10:117–122.
    doi: 10.1046/j.1365-3164.1999.00147.xpubmed: 34644932google scholar: lookup
  14. Huhmann R, Mueller R.S. A Cream Containing Omega-3-Fatty Acids, Humectants and Emollients as an Aid in the Treatment of Equine Culicoides Hypersensitivity. Vet. Dermatol. 2019;30:155-e46.
    doi: 10.1111/vde.12728pubmed: 30729602google scholar: lookup
  15. Beech J, Merryman G.S. Immunotherapy for Equine Respiratory Disease. Equine Vet. Sci. 1986;6:6–10.
    doi: 10.1016/S0737-0806(86)80072-7google scholar: lookup
  16. Francqueville M. Diagnosis and Prospects for the Treatmetn of Allergic Type Respiratory Affections in Horses. Prat. Vet. Equine. 1989;21:12–18.
  17. Fadok V.A. Hyposensitization of Equids with Allergic Skin/Pulmonary Diseases; Proceedings of the Annual Members’ Meeting (AAVD &ACVD); Las Vegas, NV, USA. 20–24 April 1996; pp. 47–48.
  18. Loeffler A, Herrick D, Allen S, Littlewood J.D. Long-Term Management of Horses with Atopic Dermatitis in Southeastern England: A Retrospective Questionnaire Study of Owners’ Perceptions. Vet. Dermatol. 2018;29:526-e176.
    doi: 10.1111/vde.12685pubmed: 30175879google scholar: lookup
  19. Radwanski N.E, Morris D.O, Boston R.C, Cerundolo R, Lee K.W. Longitudinal Evaluation of Immunological Responses to Allergen-Specific Immunotherapy in Horses with IgE Associated Dermatological Disease, a Pilot Study. Vet. Dermatol. 2019;30:255-e78.
    doi: 10.1111/vde.12732pubmed: 30828914google scholar: lookup
  20. Rees C.A. Response to Immunotherapy in Six Related Horses with Urticaria Secondary to Atopy. J. Am. Vet. Med. Assoc. 2001;218:5–7.
    doi: 10.2460/javma.2001.218.753pubmed: 11280411google scholar: lookup
  21. Carr S.H. Hyposensitization of Horses with Heaves by Injecable Allergens: A Field Report. Equine Commun. 1978;2:101–105.
  22. Tallarico N. Results of Intradermal Allergy Testing and Treatment by Hyposensitization of 64 Horses with Chronic Obstructive Pulmonary Disease, Urticaria, Headshaking, and/or Reactive Airway Disease. J. Vet. Allergy Clin. Immunol. 1998;6:25–35.
    doi: 10.1017/CBO9781107415324.004google scholar: lookup
  23. Stepnik C.T, Outerbridge C.A, White S.D, Kass P.H. Equine Atopic Skin Disease and Response to Allergen-Specific Immunotherapy: A Retrospective Study at the University of California-Davis (1991–2008). Vet. Dermatol. 2012;23:29–36.
    doi: 10.1111/j.1365-3164.2011.01001.xpubmed: 21777308google scholar: lookup
  24. Barbet J.L, Diane B, Greiner E.C. Specific Immunotherapy in the Treatment of Culicoides Hypersensitive Horses: A Double-blind Study. Equine Vet. J. 1990;22:232–235.
    doi: 10.1111/j.2042-3306.1990.tb04258.xpubmed: 2209518google scholar: lookup
  25. Anderson G.S, Belton P, Jahren E, Lange H, Kleider N. Immunotherapy Trial for Horses in British Columbia with Culicoides (Diptera: Ceratopogonidae) Hypersensitivity. J. Med. Entomol. 1996;33:458–466.
    doi: 10.1093/jmedent/33.3.458pubmed: 8667395google scholar: lookup
  26. Rosenkrantz W.S, Griffin C.E, Esch R.E, Mullens B.A. Advances in Veterinary Dermatology. Butterworth-Heinemann Ltd.; Oxford, UK: 1998. Responses in horses to intradermal challenge of insects and environmental allergens with specific immunotherapy; pp. 191–200.
  27. Ginel P.J, Hernández E, Lucena R, Blanco B, Novales M, Mozos E. Allergen-Specific Immunotherapy in Horses with Insect Bite Hypersensitivity: A Double-Blind, Randomized, Placebo-Controlled Study. Vet. Dermatol. 2014;25:29-e10.
    doi: 10.1111/vde.12092pubmed: 24267396google scholar: lookup
  28. Marteles D, Verde M.T, Conde T, Pereboom D, Casanova Á, Villanueva-Saz S, Ortín A, Fernández A. Effects of Allergen-Specific Immunotherapy on Peripheral Blood Regulatory T Cells and Serum Concentrations of Cytokines and Immunoglobulins in Horses with Allergic Dermatitis. Int. Immunopharmacol. 2019;74:105674.
    doi: 10.1016/j.intimp.2019.105674pubmed: 31195188google scholar: lookup
  29. Pfaar O, Bousquet J, Durham S.R, Kleine-Tebbe J, Larché M, Roberts G, Shamji M.H, Gerth van Wijk R. One Hundred and Ten Years of Allergen Immunotherapy: A Journey from Empiric Observation to Evidence. Allergy Eur. J. Allergy Clin. Immunol. 2022;77:454–468.
    doi: 10.1111/all.15023pubmed: 34315190google scholar: lookup
  30. Kucuksezer U.C, Ozdemir C, Cevhertas L, Ogulur I, Akdis M, Akdis C.A. Mechanisms of Allergen-Specific Immunotherapy and Allergen Tolerance. Allergol. Int. 2020;69:549–560.
    doi: 10.1016/j.alit.2020.08.002pubmed: 32900655google scholar: lookup
  31. Costa L.R.R, Seahorn T.L, Moore R.M, Taylor H.W, Gaunt S.D, Beadle R.E. Correlation of Clinical Score, Intrapleural Pressure, Cytologic Findings of Bronchoalveolar Fluid, and Histopathologic Lesions of Pulmonary Tissue in Horses with Summer Pasture-Associated Obstructive Pulmonary Disease. Am. J. Vet. Res. 2000;61:167–173.
    doi: 10.2460/ajvr.2000.61.167pubmed: 10685689google scholar: lookup
  32. Diamant Z, van Maaren M, Muraro A, Jesenak M, Striz I. Allergen Immunotherapy for Allergic Asthma: The Future Seems Bright. Respir. Med. 2023;210:107125.
    doi: 10.1016/j.rmed.2023.107125pubmed: 36702170google scholar: lookup
  33. Reinero C.R, Byerly J.R, Berghaus R.D, Berghaus L.J, Schelegle E.S, Hyde D.M, Gershwin L.J. Rush Immunotherapy in an Experimental Model of Feline Allergic Asthma. Vet. Immunol. Immunopathol. 2006;110:141–153.
    doi: 10.1016/j.vetimm.2005.09.013pubmed: 16325921google scholar: lookup
  34. Lee-Fowler T.M, Cohn L.A, DeClue A.E, Spinka C.M, Reinero C.R. Evaluation of Subcutaneous versus Mucosal (Intranasal) Allergen-Specific Rush Immunotherapy in Experimental Feline Asthma. Vet. Immunol. Immunopathol. 2009;129:49–56.
    doi: 10.1016/j.vetimm.2008.12.008pubmed: 19144412google scholar: lookup
  35. Klier J, Geis S, Steuer J, Geh K, Reese S, Fuchs S, Mueller R.S, Winter G, Gehlen H. A Comparison of Nanoparticulate CpG Immunotherapy with and without Allergens in Spontaneously Equine Asthma-affected Horses, an Animal Model. Immun. Inflamm. Dis. 2018;6:81–96.
    doi: 10.1002/iid3.198pmc: PMC5818452pubmed: 29094511google scholar: lookup
  36. Klier J, Lehmann B, Fuchs S, Reese S, Hirschmann A, Coester C, Winter G, Gehlen H. Nanoparticulate CpG Immunotherapy in RAO-Affected Horses: Phase I and IIa Study. J. Vet. Intern. Med. 2015;29:286–293.
    doi: 10.1111/jvim.12524pmc: PMC4858074pubmed: 25619520google scholar: lookup
  37. Diesel A. Equine Urticaria: A Clinical Guide to Management. In Pract. 2014;36:295–300.
    doi: 10.1136/inp.g3116google scholar: lookup
  38. Sauvé F. Can Equine Urticaria Be Cured?. Can. Vet. J. 2020;61:1001–1004.
    pmc: PMC7424928pubmed: 32879529
  39. Zuberbier T, Aberer W, Asero R, Abdul Latiff A.H, Baker D, Ballmer-Weber B, Bernstein J.A, Bindslev-Jensen C, Brzoza Z, Buense Bedrikow R. The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. Allergy 2018;73:1393–1414.
    doi: 10.1111/all.13397pubmed: 29336054google scholar: lookup
  40. Shi C.-R, Li Y.-P, Luo Y.-J, Shi C.-B, Yan X, Yang K.-H, Yi K. IgE-Mediated Allergy: A Rare Cause of Chronic Spontaneous Urticarial with Allergen-Specific Immunotherapy as Treatment Option—A Systematic Review with Meta-Analysis from China. J. Eur. Acad. Dermatol. Venereol. 2012;26:533–544.
    doi: 10.1111/j.1468-3083.2011.04302.xpubmed: 22007905google scholar: lookup
  41. Mueller R.S, Nuttall T, Prost C, Schulz B, Bizikova P. Treatment of the Feline Atopic Syndrome—A Systematic Review. Vet. Dermatol. 2021;32:43.
    doi: 10.1111/vde.12933pubmed: 33470011google scholar: lookup
  42. Mueller R.S. Update on Allergen Immunotherapy. Vet. Clin. North Am. Small Anim. Pract. 2019;49:1–7.
    doi: 10.1016/j.cvsm.2018.08.001pubmed: 30227970google scholar: lookup
  43. Kolm-Stark G, Wagner R. Intradermal Skin Testing in Icelandic Horses in Austria. Equine Vet. J. 2010;34:405–410.
    doi: 10.2746/042516402776249083pubmed: 12117115google scholar: lookup
  44. Forsyth J, Halliwell R.E, Harrand R. Co-Reactivity between Related and Unrelated Environmental Allergens in Equine Allergen-Specific IgE Serology Testing in the UK. Vet. Dermatol. 2019;30:544-e165.
    doi: 10.1111/vde.12786pubmed: 31464011google scholar: lookup
  45. Jonsdottir S, Cvitas I, Svansson V, Fettelschloss-Gabriel A, Torsteinsdottir S, Marti E. New Strategies for Prevention and Treatment of Insect Bite Hypersensitivity in Horses. Curr. Dermatol. Rep. 2019;8:303–312.
    doi: 10.1007/s13671-019-00279-wgoogle scholar: lookup
  46. Fettelschoss-Gabriel A, Fettelschoss V, Thoms F, Giese C, Daniel M, Olomski F, Kamarachev J, Birkmann K, Bühler M, Kummer M. Treating Insect-Bite Hypersensitivity in Horses with Active Vaccination against IL-5. J. Allergy Clin. Immunol. 2018;142:1194–1205.e3.
    doi: 10.1016/j.jaci.2018.01.041pubmed: 29627082google scholar: lookup
  47. Calderón M.A, Vidal C, Rodríguez del Río P, Just J, Pfaar O, Tabar A.I, Sánchez-Machín I, Bubel P, Borja J, Eberle P. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A Real-Life Clinical Assessment. Allergy Eur. J. Allergy Clin. Immunol. 2017;72:462–472.
    doi: 10.1111/all.13066pubmed: 27718250google scholar: lookup
  48. Aue A, Ho J, Zhu R, Kim H, Jeimy S. Systemic Reactions to Subcutaneous Allergen Immunotherapy: Real-World Cause and Effect Modelling. Allergy Asthma Clin. Immunol. 2021;17:65.
    doi: 10.1186/s13223-021-00566-xpmc: PMC8262003pubmed: 34229743google scholar: lookup
  49. James C, Bernstein D.I. Allergen Immunotherapy: An Updated Review of Safety. Curr. Opin. Allergy Clin. Immunol. 2017;17:55–59.
    doi: 10.1097/ACI.0000000000000335pmc: PMC5644500pubmed: 27906697google scholar: lookup
  50. Deboer D.J, Verbrugge M, Morris M. Clinical and Immunological Responses of Dust Mite Sensitive, Atopic Dogs to Treatment with Sublingual Immunotherapy (SLIT). Vet. Dermatol. 2016;27:82-e24.
    doi: 10.1111/vde.12284pubmed: 26749020google scholar: lookup
  51. Scholz F.M, Burrows A.K, Muse R. First Report of Angio-Oedema Subsequent to the Administration of Allergen Specific Sublingual Immunotherapy for the Management of Equine Hypersensitivity Dermatitis. Vet. Dermatol. 2016;27:439–442.
    doi: 10.1111/vde.12349pubmed: 27350603google scholar: lookup
  52. Olivry T, Bensignor E, Favrot C, Griffin C.E, Hill P.B, Mueller R.S, Plant J.D, Williams H.C. Development of a Core Outcome Set for Therapeutic Clinical Trials Enrolling Dogs with Atopic Dermatitis (COSCAD’18). BMC Vet. Res. 2018;14:238.
    doi: 10.1186/s12917-018-1569-ypmc: PMC6097451pubmed: 30115047google scholar: lookup
  53. DeBoer D.J. The Future of Immunotherapy for Canine Atopic Dermatitis: A Review. Vet. Dermatol. 2017;28:25-e6.
    doi: 10.1111/vde.12416pubmed: 28133873google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.